Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2021 2
2022 2
Text availability
Article attribute
Article type
Publication date

Search Results

4 results
Results by year
Filters applied: . Clear all
Page 1
Lorlatinib in ALK-Rearranged Lung Cancer.
Kuang S, Leighl NB. Kuang S, et al. Cancer Cell. 2021 Jan 11;39(1):25-27. doi: 10.1016/j.ccell.2020.12.017. Cancer Cell. 2021. PMID: 33434512 Free article.
Concurrent Chemoradiation With or Without Durvalumab in Elderly Patients With Unresectable Stage III NSCLC: Safety and Efficacy.
Lau SCM, Ryan M, Weiss J, Fares AF, Garcia M, Schmid S, Kuang S, Kelly D, Tsao MS, Bradbury PA, Cho BCJ, Sun A, Raman S, Hope A, Giuliani M, Lok BH, Bezjak A, Liu G, Leighl NB, Shepherd FA, Sacher AG. Lau SCM, et al. Among authors: kuang s. JTO Clin Res Rep. 2021 Nov 2;2(12):100251. doi: 10.1016/j.jtocrr.2021.100251. eCollection 2021 Dec. JTO Clin Res Rep. 2021. PMID: 34917991 Free PMC article.
Upfront Next Generation Sequencing in Non-Small Cell Lung Cancer.
Kuang S, Fung AS, Perdrizet KA, Chen K, Li JJN, Le LW, Cabanero M, Karsaneh OAA, Tsao MS, Morganstein J, Ranich L, Smith AC, Wei C, Cheung C, Shepherd FA, Liu G, Bradbury P, Pal P, Schwock J, Sacher AG, Law JH, Stockley TL, Leighl NB. Kuang S, et al. Curr Oncol. 2022 Jun 22;29(7):4428-4437. doi: 10.3390/curroncol29070352. Curr Oncol. 2022. PMID: 35877212 Free PMC article.